Phase II Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil Chemotherapy in Squamous Cell Carcinoma of the Oral Cavity With Molecular Endpoints.
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2017
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 06 Dec 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 Dec 2010 Planned End Date changed from 1 Jan 2020 to 1 Sep 2009 as reported by ClinicalTrials.gov.
- 01 Oct 2008 Planned number of patients changed from 20 to 60, according to ClinicalTrials.gov.